AngioDynamics Announces Publication of DIRECT Study Results and New Category I CPT Code for Pancreatic IREBusiness Wire • 10/21/26
AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver CancerBusiness Wire • 10/14/26
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/YZacks Investment Research • 10/09/26
AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and ProfitabilityBusiness Wire • 10/08/26
AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive OfficerBusiness Wire • 10/08/26
AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism EvidenceBusiness Wire • 10/02/26
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 08/13/26
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?Zacks Investment Research • 08/06/26
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in FocusZacks Investment Research • 08/06/26
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year ProfitabilityBusiness Wire • 07/14/26